Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic ...

2017年06月， 哈尔滨医科大学附属第一医院 在Oncotarget上在线发表了一篇论文。在 发表7年后 ，因 图片组内重复 在pubpeer上被读者质疑。 论文题为 “MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3 (MTA3) in ...

根据相关研究，肾透明细胞癌是最常见的肾癌类型，约占所有肾癌病例的70%。尽早且有效的治疗方法对改善患者的存活率至关重要。通过与新加坡科研机构的深度合作，晶泰科技不仅利用其技术优势，还借助合作方的临床经验和科研资源，进一步提升药物研发的科学性和有效性。

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, ...

Now scientists have found a possible source of this variability in clear cell renal cell carcinoma (ccRCC) -- the most common kidney cancer diagnosed in adults. Fighting cancer can seem like a ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated ...

Harbor Laboratory Assistant Professor Katherine Alexander has identified two patterns of nuclear speckles in the most common form of kidney cancer. Her research at the University of Pennsylvania ...

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...